The potential influence of inflammation and insulin resistance on the pathogenesis and treatment of atherosclerosis-related complications in type 2 diabetes.
Dandona
Paresh
P
Division of Endocrinology, Diabetes and Metabolism, State University of New York at Buffalo and Kaleida Health, Buffalo, New York 14209, USA. pdandona@kaleidahealth.org
Aljada
Ahmad
A
Chaudhuri
Ajay
A
Bandyopadhyay
Arindam
A
D001161:Arteriosclerosis / Q000188:drug therapy* / Q000209:etiology*; D002317:Cardiovascular Agents / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2; D003925:Diabetic Angiopathies / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007249:Inflammation / Q000150:complications*; D007333:Insulin Resistance
D002317:Cardiovascular Agents; D007004:Hypoglycemic Agents